Clinical Trial Update: Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating how gut microbiota might affect outcomes in liver cancer patients treated with a combination of tyrosine kinase inhibitors and immune…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Xu Yong, MD | Conditions: Liver Cancer | Phase 2 | Status: NOT_YET_RECRUITING